Drugmakers race to find a place in the next wave of obesity drugs

by admin | Jun 13, 2026 | Economy_finances

Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.

← Chart of the Week: US headline inflation matters to consumers Rivian CEO taking different approach than Elon Musk for humanoid robotics company →

Written By

Written by Albert Pham, News Curator and Blogger

The $115 Billion AI Bet: Why Marvell Is Buying Lumentum to Challenge the Semiconductor Giants

Nov 2, 2026 | albertpham, Economy_finances, Technology

Marvell’s planned acquisition of Lumentum marks a bold move to shape how tomorrow’s AI data centres connect and communicate. The combination reaches beyond chips, bringing optical technology into focus as companies race to build faster, more capable computing infrastructure.

Asian Brands Fuel Ho Chi Minh City Retail Boom as Occupancy Hits 96.6%

Nov 2, 2026 | albertpham, Asia, Economy_finances

Explore how Asian brands, rising consumer spending and demand for prime locations are reshaping Ho Chi Minh City retail. Discover the market trends influencing occupancy, leasing and new opportunities across Vietnam.

China’s Growing Navy Challenges U.S. Maritime Dominance Under Xi Jinping

Nov 2, 2026 | albertpham, Asia, Economy_finances, Politics

China’s naval rise is reshaping the strategic landscape, with growing fleets and shipbuilding capacity bringing new pressure to U.S. influence across the Indo-Pacific. Explore what this competition could mean for regional security, global trade and the future of maritime power.

Drugmakers race to find a place in the next wave of obesity drugs

Written By

Related Posts

The $115 Billion AI Bet: Why Marvell Is Buying Lumentum to Challenge the Semiconductor Giants

Asian Brands Fuel Ho Chi Minh City Retail Boom as Occupancy Hits 96.6%

China’s Growing Navy Challenges U.S. Maritime Dominance Under Xi Jinping

0 Comments